Ms. Mette Kirstine Agger, M.Sc., MBA serves as Managing Partner and Executive Director of Lundbeckfond Ventures. Ms. Agger serves as the Head of LFI Life Science Investments A/S. She serves as Managing Partner at Lundbeckfond Invest A/S. She serves as an Executive Director of LFI Life Science Investments A/S and H. Lundbeck A.S, Investment Arm. She is employed at Lundbeckfond Invest A/S. She joined LFI A/S on September 1, 2009. She has broad international experience within biotech / life science covering business development and licensing, management and financing. She co-founded 7TM Pharma A/S in 2000 and served as its Chief Executive Officer. She served as a Co-Chief Executive Officer of Harboes Bryggeri A/S. She served as the Chairman of Veloxis Pharmaceuticals A/S until April 20, 2016. She served as the Chairman of Sophion Bioscience and Klifo A/S. She served as a Director of Business Development, Licensing and Patents at NeuroSearch A/S and a Member of the Management Team from 1996 to 2002. She was responsible for and actively completed all licensing and collaboration agreements for NeuroSearch, including a number of agreements with the largest pharmaceutical companies. She is very actively involved in and co-founded a number of new biotech companies. She started her career as Patent Agent at the Patent Law firm Plougmann, Vingtoft & Partners with focus on biotech.

She has been Deputy Chairman at Veloxis Pharmaceuticals A/S since April 20, 2016. She has been an Independent Director of Veloxis Pharmaceuticals A/S since April 21, 2010. She has been a Director of Thesan Pharmaceuticals, Inc., since February 24, 2014. She has been a Director at Trevi Therapeutics, Inc. since July 20, 2017. She has been an Independent Director of Cydan Development, Inc. since October 1, 2013, AlloCure, Inc. since April 2, 2012. She serves as an Investor Director of PsiOxus Therapeutics Limited. She serves as a Member of the Institute Council at Statens Serum Institut. She serves as a Director of Harboe Breweries A/S, Vtesse, Inc., Symbion Forskerpark; Breweries A/S , Imara, Inc and Risø National Laboratories. She serves on the Board of scPharmaceuticals. She served as a Director of EpiTherapeutics ApS. She served as a Director of Harboes Bryggeri A/S since 2008. She served as a Director of DBV Technologies S.A., and Danish Bio-industry association, FBID. She holds B.Sc. and M.S. in Biology from the University of Copenhagen and an M.B.A. from Henley Management College.